BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the Nephrocare Health Services Limited IPO: Step-by-Step Investment Guide

Nephrocare Health Services Ltd. operates a network of dialysis clinics offering diagnosis, haemodialysis, home and mobile dialysis, and related wellness programmes supported by an internal pharmacy model. The organisation functions across multiple regions in India and selected international locations through clinic-based operations and partnerships with hospitals to manage in-house dialysis centres. Its presence across several cities, including tier II and tier III locations, positions the company within a segment that addresses growing demand for structured dialysis care. The business approach reflects a focus on accessible dialysis treatment supported by a diversified service offering within the kidney care space.

Investors can apply for the IPO online through supported platforms using the ASBA facility available in their bank account. The application can be submitted by logging into the net banking portal, selecting the IPO section, choosing the relevant offering, and placing a bid within the available price range. Another option is to apply through authorised broking platforms by completing the application form and using the UPI process, subject to the application window and eligibility conditions as published in official exchange communication. Applicants may refer to the company’s prospectus and exchange filings before making any investment decision.

For more details, visit the Nephrocare Health Services Limited IPO page.

Nephrocare Health Services Limited IPO Details and Objectives

Details

Information

IPO Date

December 10, 2025 to December 12, 2025

Issue Size

1,89,35,819 shares (aggregating up to ₹871.05 Cr)

Price Band

₹438 to ₹460 per share

Lot Size

32 shares

Listing At

BSE, NSE

Purpose of the IPO

  • Capital expenditure by the Company for opening new dialysis clinics in India

  • Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company

  • General corporate purposes

Timeline of Nephrocare Health Services Limited IPO

Event

Date

IPO Open Date

Wed, Dec 10, 2025

IPO Close Date

Fri, Dec 12, 2025

Tentative Allotment

Mon, Dec 15, 2025

Initiation of Refunds

Tue, Dec 16, 2025

Credit of Shares to Demat

Tue, Dec 16, 2025

Tentative Listing Date

Wed, Dec 17, 2025

Cut-off time for UPI mandate confirmation

5 PM on Fri, Dec 12, 2025

Pricing & Lot Size of Nephrocare Health Services Limited IPO

Price Band for the IPO

  •  ₹438 to ₹460 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

32

₹14,720

Retail (Max)

13

416

₹1,91,360

S-HNI (Min)

14

448

₹2,06,080

S-HNI (Max)

67

2,144

₹9,86,240

B-HNI (Min)

68

2,176

₹10,00,960

Nephrocare Health Services Limited IPO Application Process

The Nephrocare Health Services Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Nephrocare Health Services Limited IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (lot size: 32 shares) within the price band of ₹438 to ₹460 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹666.23 crore in FY23 to ₹1,193.68 crore as of Sept 2025.

  • Total income: Reached ₹483.97 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹14.23 crore for Sept 2025.

  • Net Worth: Recorded at ₹716.06 crore in FY25.

  • Reserves and surplus: Stood at ₹704.14 crore in FY25.

  • EBITDA: Stood at ₹110.31 crore in Sept 2025.

Recent Performance and Growth Prospects

  • The company recorded an increase in its total assets over the recent financial periods, reflecting expansion in its operational base and investments.

  • Total income showed consistent growth during the latest financial year, supported by the scale of its clinic network and service portfolio.

  • Profit after tax remained positive during the latest reporting period, indicating a stable earnings position.

  • Net worth increased over time, supported by retained earnings and internal reserves.

  • Reserves and surplus strengthened during the reporting period, reflecting accumulated profits and a more resilient balance sheet.

  • Operating performance showed a positive earnings contribution before interest, tax, depreciation, and amortisation in the latest period, indicating continued operational activity across the network.

  • Overall financial trends suggest an expansion in business scale supported by asset growth, rising income, and steady profitability.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The business operates in a specialised healthcare segment where performance may depend on regulatory requirements, reimbursement policies, and operational compliance across multiple locations.

  • Expansion into new regions and continuous clinic management may involve costs, capacity planning, and availability of qualified medical personnel, which can influence financial outcomes.

Opportunities and Growth Potential

  • The company has a presence across several cities, including tier II and tier III locations, which indicates access to a wider patient base requiring structured dialysis care.

  • Partnerships with hospitals for in-house dialysis centres and the availability of diversified dialysis formats, including home and mobile services, may support expansion of its service portfolio.

Key Performance Indicator (KPI)

KPI

Values

ROE

13.45%

ROCE

18.67%

RoNW

13.19%

PAT Margin

8.88%

EBITDA Margin

22.05%

Price-to-Book Value

7.72

Nephrocare Health Services Limited IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Kfin Technologies Ltd. 

ICICI Securities Ltd.

Company Address of Nephrocare Health Services Limited

Nephrocare Health Services Ltd. 

5th Floor, D Block, iLabs Centre,

Plot 18, Software Units Layout,

Survey No. 64, Madhapur, Shaikpet,

Hyderabad, Telangana, 500081

Phone: +91 40 4240 8039

Email: cs@nephroplus.com

Website: http://www.nephroplus.com/

Conclusion

The Nephrocare Health Services Limited IPO provides information on the company’s dialysis clinic network, its service portfolio, and its presence across several regions in India and selected international locations. The organisation operates through a combination of standalone clinics and partnerships with hospitals for in-house dialysis centres, creating multiple access points for treatment. The offering also includes details related to the issue structure, price band, timeline, and the stated objectives in the prospectus.

Applicants can review the information presented in the draft red herring prospectus and refer to official exchange filings to understand the operational and financial history of the company. The decision to apply may be supported through the ASBA facility in eligible bank accounts or through authorised broking platforms during the subscription period. Investors may consider reviewing disclosures on risks, business structure, and regulatory aspects before completing any application.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Nephrocare Health Services IPO allotment status.

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|